Nitric oxide (NO) has been shown to exert cytotoxic effects on tumor cells. W e have reported that EC2 I 9 cells, a rat-brainmicrovessel-derived endothelial cell line, produced NO through cytokine-inducible NO synthase (iNOS), the induction of which was significantly decreased by (a) soluble factor(
Karyotype evolution in a transformed rat cerebral endothelial cell line
โ Scribed by Michael Tyrkus; Clement A. Diglio; Norma Gohle
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- French
- Weight
- 560 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Primary cultures of rat microvascular endothelial cells were transformed, in vitro, by exposure to Rous sarcoma virus. Transformed cells were followed and evaluated cytogenetically through numerous passages. Highly specific karyotypic changes in karyotype (both structural and numerical) were documented. These changes became established and intimately involved in further โkaryotypic evolutionโ. The findings were reproducible, and when considered in the light of the literature suggest regular patterns of karyotypic change in rat tumors. The in vitro methodology utilized promises to be of practical value in the study of the early stages of malignancy.
๐ SIMILAR VOLUMES
## Abstract Intravenous administration of human mesenchymal stem cells (hMSCs) prepared from adult bone marrow has been reported to ameliorate functional deficits after cerebral artery occlusion in rats. Several hypotheses to account for these therapeutic effects have been suggested, and current th
The cyclin kinase inhibitor p16, encoded by the CDKN2A gene, suppresses the transformation of mouse embryonic fibroblasts by oncogenic RAS. In contrast, the c-JUN transcription factor (a major component of AP-1) has been suggested to be required for RAS transformation of rodent fibroblasts. The CDKN
## Abstract We conducted an experiment to determine whether expression of transforming growth factorโฮฑ (TGFโฮฑ) enhances tumorigenicity in a lowโtumorigenicity rat bladder carcinoma cell line and whether it is sufficient to induce a tumorigenic phenotype in a nontumorigenic rat bladder cell line. D4